Sepsis, low platelet nadir at mobilization and previous IFN use predict stem cell mobilization failure in patients with multiple myeloma

Cytotherapy

Volumn 9, Issue 6, 2007, Pages 548-554

  Putkonen, Mervi ^a   Rauhala, A ^b   Pelliniemi, T T ^a   Remes, K ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Autologous blood cell transplantation; CD34+ cells; Multiple myeloma; Stem cell mobilization

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; INTERFERON; MOLGRASTIM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CONTROL; CANCER GROWTH; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG USE; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SEPSIS; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT FAILURE;

ADULT; AGED; ANTIGENS, CD34; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INTERFERONS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLATELET COUNT; REGRESSION ANALYSIS; SEPSIS; TREATMENT FAILURE;

EID: 34648825228     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240701508429     Document Type: Article

References (36)

1. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood, 74, pp. 1905-1914.
2. Alegre, A., Tomas, JF and Martinez-Chamorro, C. (1997) Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: High-dose cyclophosphamide plus GM-CSF vs G-CSF alone. Bone Marrow Transplant, 20, pp. 211-217.
3. Desikan, KR, Barlogie, B. and Jagannath, S. (1998) Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma. J Clin Oncol, 16, pp. 1547-1553.
4. Haas, R., Möhle, R. and Fruhauf, S. (1994) Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood, 83, pp. 3787-3794.
5. + cells after stem cell mobilization predict stem cell yield and post-transplant hematopoietic recovery. J Hematother, 6, pp. 13-19.
6. Bensinger, WI, Longin, K. and Appelbaum, F. (1994) Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol, 87, pp. 825-831.
7. Bensinger, W., Appelbaum, F. and Rowley, S. (1995) Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol, 13, pp. 2547-2555.
8. Goldschmidt, H., Hegenbart, U. and Haas, R. (1996) Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte stimulating factor in patients with multiple myeloma. Bone Marrow Transplant, 17, pp. 691-697.
9. Watts, MJ, Sullivan, AM and Jamieson, E. (1997) Progenitor cell mobilisation after low-dose cyclophosphamide and G-CSF: An analysis of progenitor cell quality and factors predicting for these parameters in 101 pre-treated patients with malignant lymphoma. J Clin Oncol, 15, pp. 535-546.
10. Dreger, P., Kloss, M. and Petersen, B. (1995) Autologous progenitor cell transplantation: Prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cells but not of bone marrow grafts. Blood, 86, pp. 3970-3978.
11. Drake, M., Ranaghan, L. and Morris, TCM (1997) Analysis of the effect of prior chemotherapy on progenitor cell yield: Use of a chemotherapy scoring system. Br J Haematol, 98, pp. 745-749.
12. Blade, J., Samson, D. and Reece, D. (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Br J Haematol, 102, pp. 1115-1123.
13. + cell analysis: Technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. J Hematother, 4, pp. 21-28.
14. + cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant, 17, pp. 509-515.
15. Engelhardt, M., Winkler, J. and Waller, C. (1997) Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF. Bone Marrow Transplant, 19, pp. 529-537.
16. Koumakis, G., Vassilomanolakis, M. and Hatzichristou, H. (1996) Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies. Bone Marrow Transplant, 18, pp. 1065-1072.
17. Clark, RE and Brammer, CG. (1998) Previous treatment predicts the efficiency of blood progenitor cell mobilisation: Validation of a chemotherapy scoring system. Bone Marrow Transplant, 22, pp. 859-863.
18. Marit, G., Thiessard, F. and Faberes, C. (1998) Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: A monocentric study. Leukemia, 12, pp. 1447-1456.
19. Tricot, G., Jagannath, S. and Vesole, D. (1995) Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood, 85, pp. 588-596.
20. Prince, HM, Imrie, K. and Sutherland, DR (1996) Peripheral blood progenitor cell collections in multiple myeloma: Predictors and management of inadequate collections. Br J Haematol, 93, pp. 142-145.
21. Kotasek, D., Shepherd, KM and Sage, RE (1992) Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant, 9, pp. 11-17.
22. Tarella, C., Boccadoro, M. and Omede, P. (1993) Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple meyloma. Bone Marrow Transplant, 11, pp. 271-277.
23. Demirer, T., Buckner, CD and Gooley, T. (1996) Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant, 17, pp. 937-941.
24. Goldschmidt, H., Hegenbart, U. and Wallmeier, M. (1997) Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma. Br J Haematol, 98, pp. 736-744.
25. Wahlin, A., Eriksson, M. and Hultdin, M. (2004) Relation between harvest success and outcome after autologous peripheral blood stem cell transplantation in multiple myeloma. Eur J Haemat, 73, pp. 263-288.
26. To, LB, Shepperd, MK and Haylock, D. (1990) Single high doses of cyclophosphamide enable the collection of high numbers of stem cells from the peripheral blood. Exp Hematol, 18, pp. 442-447.
27. Boiron, J-M, Marit, G. and Faberes, C. (1993) Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). Bone Marrow Transplant, 12, pp. 49-55.
28. Fitoussi, O., Perreau, V. and Boiron, JM (2001) A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients. Bone Marrow Transplant, 27, pp. 837-842.
29. Johnson, PRE, Fitzsimmons, CL and Chang, J. (1995) Infection at the time of peripheral blood stem cell leukapheresis results in reduced granulocyte-macrophage colony forming unit yields. Br J Haematol, 89, pp. 689-690.
30. Jantunen, E., Putkonen, M. and Nousiainen, T. (2003) Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma. Bone Marrow Transplant, 31, pp. 347-351.
31. Lerro, KA and Medoff, E. (2003) A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents. Bone Marrow Transplant, 32, pp. 1113-1117.
32. Russell, NH, McQuaker, G. and Stainer, C. (1998) Stem cell mobilisation in lymphoproliferative diseases. Bone Marrow Transplant, 22, pp. 935-940.
33. Kröger, N., Zeller, W. and Fehse, N. (1998) Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients. Br J Haematol, 102, pp. 1101-1106.
34. Lie, AKW, Hui, CH and Rawling, T. (1998) Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSF. Bone Marrow Transplant, 22, pp. 853-857.
35. Glaspy, JA, Shpall, EJ and LeMaistre, CF (1997) Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood, 90, pp. 2939-2951.
36. Weaver, A., Chang, J. and Wrigley, E. (1998) Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer. J Clin Oncol, 16, pp. 2601-2612.